{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,27]],"date-time":"2026-03-27T00:47:09Z","timestamp":1774572429781,"version":"3.50.1"},"reference-count":18,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2019,8,9]],"date-time":"2019-08-09T00:00:00Z","timestamp":1565308800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,8,9]],"date-time":"2019-08-09T00:00:00Z","timestamp":1565308800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Surg Endosc"],"published-print":{"date-parts":[[2020,6]]},"DOI":"10.1007\/s00464-019-07029-w","type":"journal-article","created":{"date-parts":[[2019,8,9]],"date-time":"2019-08-09T17:02:26Z","timestamp":1565370146000},"page":"2601-2607","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["The outcome of fundoplication in patients with GERD based on abnormal impedance testing"],"prefix":"10.1007","volume":"34","author":[{"given":"M. E.","family":"Glasgow","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8320-5428","authenticated-orcid":false,"given":"C. M.","family":"Dunst","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"W. F.","family":"Abdelmoaty","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"N.","family":"Setthavongsack","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H.","family":"Creasey","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D.","family":"Davila Bradley","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K. M.","family":"Reavis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L. L.","family":"Swanstrom","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S. R.","family":"Demeester","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,8,9]]},"reference":[{"key":"7029_CR1","doi-asserted-by":"publisher","first-page":"710","DOI":"10.1136\/gut.2004.051821","volume":"54","author":"J Dent","year":"2005","unstructured":"Dent J, El-Serag HB, Wallander MA et al (2005) Epidemiology of gastrooesophageal reflux disease: a systematic review. Gut 54:710\u2013717","journal-title":"Gut"},{"key":"7029_CR2","doi-asserted-by":"publisher","first-page":"1383","DOI":"10.1053\/j.gastro.2008.08.045","volume":"135","author":"PJ Kahrilas","year":"2008","unstructured":"Kahrilas PJ, Shaheen NJ, Vaezi MF (2008) American Gastroenterological Association Institute technical review on the management of gastroesophageal reflux disease. Gastroenterology 135:1383\u20131413","journal-title":"Gastroenterology"},{"key":"7029_CR3","doi-asserted-by":"publisher","first-page":"1940","DOI":"10.1111\/j.1572-0241.2003.07665.x","volume":"98","author":"JM Inadomi","year":"2003","unstructured":"Inadomi JM, McIntyre L, Bernard L, Fendrick AM (2003) Step-down from multiple to single-dose proton pump inhibitors (PPIs): a prospective study of patients with heartburn or acid regurgitation completely relieved with PPIs. Am J Gastroenterol 98:1940\u20131944","journal-title":"Am J Gastroenterol"},{"key":"7029_CR4","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1016\/S1091-255X(99)80071-7","volume":"3","author":"GM Campos","year":"1999","unstructured":"Campos GM, Peters JH, DeMeester TR, Oberg S, Crookes PF, Tan S et al (1999) Multivariate analysis of factors predicting outcome after laparoscopic Nissen fundoplication. J Gastrointest Surg 3:292\u2013300","journal-title":"J Gastrointest Surg"},{"issue":"9","key":"7029_CR5","doi-asserted-by":"publisher","first-page":"1267","DOI":"10.1111\/nmo.12620","volume":"27","author":"TV Herregods","year":"2015","unstructured":"Herregods TV, Troelstra M, Weijenborg PW, Bredenoord AJ, Smout AJ (2015) Patients with refractory reflux symptoms often do not have GERD. Neurogastroenterol Motil 27(9):1267\u20131273","journal-title":"Neurogastroenterol Motil"},{"key":"7029_CR6","doi-asserted-by":"publisher","first-page":"917","DOI":"10.1016\/j.gie.2008.09.022","volume":"69","author":"JE Pandolfino","year":"2009","unstructured":"Pandolfino JE, Vela MF (2009) Esophageal reflux monitoring. Gastrointest Endosc 69:917\u2013930","journal-title":"Gastrointest Endosc"},{"issue":"1","key":"7029_CR7","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1016\/j.cgh.2008.08.020","volume":"7","author":"S Ayazi","year":"2009","unstructured":"Ayazi S, Lipham JC, Portale G, Peyre CG, Streets CG, Leers JM, DeMeester SR, Banki F, Chan LS, Hagen JA, DeMeester TR (2009) Bravo catheter-free pH monitoring: normal values, concordance, optimal diagnostic thresholds, and accuracy. Clin Gastroenterol Hepatol 7(1):60\u201367","journal-title":"Clin Gastroenterol Hepatol"},{"key":"7029_CR8","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1097\/MCG.0b013e31815f8e17","volume":"42","author":"A Agrawal","year":"2008","unstructured":"Agrawal A, Castell D (2008) Clinical importance of impedance measurements. J Clin Gastroenterol 42:579\u2013583","journal-title":"J Clin Gastroenterol"},{"key":"7029_CR9","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1111\/j.1365-2982.1991.tb00061.x","volume":"3","author":"J Silny","year":"1991","unstructured":"Silny J (1991) Intraluminal multiple electric impedance procedure for measurement of gastrointestinal motility. J Gastrointest Motil 3:151\u2013162","journal-title":"J Gastrointest Motil"},{"issue":"Suppl 2","key":"7029_CR10","first-page":"A171","volume":"130","author":"R Tutuian","year":"2006","unstructured":"Tutuian R, Mainie I, Agrawal A et al (2006) Normal values for ambulatory 24-h combined impedance-pH monitoring on acid suppressive therapy. Gastroenterology 130(Suppl 2):A171","journal-title":"Gastroenterology"},{"key":"7029_CR11","doi-asserted-by":"publisher","first-page":"1301","DOI":"10.1007\/s11605-019-04148-6","volume":"23","author":"MA Ward","year":"2019","unstructured":"Ward MA, Dunst CM, Glasgow ME, Teitelbaum EN, Abdelmoaty WF, Reavis KM, Swanstr\u04e7m LL, DeMeester SR (2019) Can impedance-pH testing on medications reliably identify patients with GERD as defined by pathologic esophageal acid exposure off medications? J Gastrointest Surg 23:1301\u20131308","journal-title":"J Gastrointest Surg"},{"key":"7029_CR12","doi-asserted-by":"publisher","first-page":"1483","DOI":"10.1002\/bjs.5493","volume":"95","author":"I Mainie","year":"2006","unstructured":"Mainie I, Tutuian R, Argawal A, Adams D, Castell DO (2006) Combined multichannel intraluminal impedance-pH monitoring to select patients with persistent gastro-oesophageal reflux for laparoscopic Nissen fundoplication. Br J Surg Soc 95:1483\u20131487","journal-title":"Br J Surg Soc"},{"key":"7029_CR13","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1007\/s11605-011-1741-1","volume":"16","author":"T Hoppo","year":"2012","unstructured":"Hoppo T, Sanz AF, Nason KS, Carroll TL, Rosen C, Normolle DP, Shaheen NJ, Luketich JD, Jobe AB (2012) How much pharyngeal exposure is \u201cnormal\u201d? Normative data for laryngopharyngeal reflux events using hypopharyngeal multichannel intraluminal impedance (HMII). J Gastrointest Surg 16:16\u201325","journal-title":"J Gastrointest Surg"},{"key":"7029_CR14","doi-asserted-by":"publisher","first-page":"1011","DOI":"10.1111\/j.1365-2036.2005.02677.x","volume":"22","author":"F Zerbib","year":"2005","unstructured":"Zerbib F, des Varannes S, Roman S et al (2005) Normal values and day-to-day variability of 24-h ambulatory oesophageal impedance-pH monitoring in a Belgian; French cohort of healthy subjects. Aliment Pharmacol Ther 22:1011\u20131021","journal-title":"Aliment Pharmacol Ther"},{"issue":"4","key":"7029_CR15","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1016\/j.dld.2005.12.011","volume":"38","author":"P Zentilin","year":"2006","unstructured":"Zentilin P, Iiritano E, Dulbecco P, Bilardi C, Savarino E, De Conca S, Parodi A, Reglioni S, Vigneri S, Savarino V (2006) Normal values of 24-h ambulatory intraluminal impedance combined with pH-metry in subjects eating a Mediterranean diet. Digest Liver Dis 38(4):226\u2013232","journal-title":"Digest Liver Dis"},{"issue":"2","key":"7029_CR16","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1159\/000209220","volume":"79","author":"YL Xiao","year":"2009","unstructured":"Xiao YL, Lin JK, Cheung TK, Wong NY, Yang L, Hung IF, Wong BC, Chen MH (2009) Normal values of 24-hour combined esophageal multichannel intraluminal impedance and pH monitoring in the Chinese population. Digestion 79(2):109\u2013114","journal-title":"Digestion"},{"issue":"1","key":"7029_CR17","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1016\/j.cgh.2008.08.020","volume":"7","author":"S Ayazi","year":"2009","unstructured":"Ayazi S, Lipham JC, Portale G, Peyre CG, Streets CG, Leers JM, Demeester SR, Banki F, Chan LS, Hagen JA, Demeester TR (2009) Bravo catheter-free pH monitoring: normal values, concordance, optimal diagnostic thresholds, and accuracy. Clin Gastroenerol Hepatol 7(1):60\u201367","journal-title":"Clin Gastroenerol Hepatol"},{"issue":"9","key":"7029_CR18","doi-asserted-by":"publisher","first-page":"816","DOI":"10.1097\/MCG.0b013e318194592b","volume":"43","author":"W Blonski","year":"2009","unstructured":"Blonski W, Vela M, Castell D (2009) Comparison of reflux frequency during prolonged multichannel intraluminal impedance and pH monitoring On and Off acid suppression therapy. J Clin Gastroenterol 43(9):816\u2013820","journal-title":"J Clin Gastroenterol"}],"container-title":["Surgical Endoscopy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00464-019-07029-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00464-019-07029-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00464-019-07029-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,8,7]],"date-time":"2020-08-07T23:07:46Z","timestamp":1596841666000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00464-019-07029-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,8,9]]},"references-count":18,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2020,6]]}},"alternative-id":["7029"],"URL":"https:\/\/doi.org\/10.1007\/s00464-019-07029-w","relation":{},"ISSN":["0930-2794","1432-2218"],"issn-type":[{"value":"0930-2794","type":"print"},{"value":"1432-2218","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,8,9]]},"assertion":[{"value":"28 April 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 July 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 August 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"Dr. Reavis is a consultant for Boston Scientific, Endogastric Solutions, and Stryker, and receives teaching or advisory honoraria from Ethicon, Mederi, Gore, and Apollo. Dr. Swanstrom is on the scientific advisory boards of Olympus, Apollo, Titan, and Boston Scientific. Dr. DeMeester is a consultant for Bard, Gore, Endogastric Solutions, C2 Therapeutics, Novadaq, Mauna Kea, and CDx Diagnostics. Dr. Dunst is a consultant for Bard Davol. These disclosures are not relevant to the current study.Authors Matt Glasgow, Naly Setthavongsack, Hannah Creasey, Dr. Davila Bradley, and Dr. Abdelmoaty have no disclosures.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclosures"}}]}}